Scientists hunt for clues to stop nerve disease before it starts
NCT ID NCT07476365
First seen Mar 22, 2026 · Last updated May 25, 2026 · Updated 8 times
Summary
This study looks for early warning signs (biomarkers) of Charcot-Marie-Tooth 1A (CMT1A) in people aged 10 to 30. Researchers will analyze blood, skin, and nerve data from both rats and humans to find markers that predict how the disease will progress. The goal is to make future clinical trials possible in children, so treatments can start early and prevent nerve damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre
RECRUITINGGöttingen, 37075, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.